174 related articles for article (PubMed ID: 20923550)
1. Sensitive detection of Aβ protofibrils by proximity ligation--relevance for Alzheimer's disease.
Kamali-Moghaddam M; Pettersson FE; Wu D; Englund H; Darmanis S; Lord A; Tavoosidana G; Sehlin D; Gustafsdottir S; Nilsson LN; Lannfelt L; Landegren U
BMC Neurosci; 2010 Oct; 11():124. PubMed ID: 20923550
[TBL] [Abstract][Full Text] [Related]
2. The murine version of BAN2401 (mAb158) selectively reduces amyloid-β protofibrils in brain and cerebrospinal fluid of tg-ArcSwe mice.
Tucker S; Möller C; Tegerstedt K; Lord A; Laudon H; Sjödahl J; Söderberg L; Spens E; Sahlin C; Waara ER; Satlin A; Gellerfors P; Osswald G; Lannfelt L
J Alzheimers Dis; 2015; 43(2):575-88. PubMed ID: 25096615
[TBL] [Abstract][Full Text] [Related]
3. Sensitive ELISA detection of amyloid-beta protofibrils in biological samples.
Englund H; Sehlin D; Johansson AS; Nilsson LN; Gellerfors P; Paulie S; Lannfelt L; Pettersson FE
J Neurochem; 2007 Oct; 103(1):334-45. PubMed ID: 17623042
[TBL] [Abstract][Full Text] [Related]
4. Novel multivalent design of a monoclonal antibody improves binding strength to soluble aggregates of amyloid beta.
Rofo F; Buijs J; Falk R; Honek K; Lannfelt L; Lilja AM; Metzendorf NG; Gustavsson T; Sehlin D; Söderberg L; Hultqvist G
Transl Neurodegener; 2021 Sep; 10(1):38. PubMed ID: 34579778
[TBL] [Abstract][Full Text] [Related]
5. The conformational epitope for a new Aβ42 protofibril-selective antibody partially overlaps with the peptide N-terminal region.
Colvin BA; Rogers VA; Kulas JA; Ridgway EA; Amtashar FS; Combs CK; Nichols MR
J Neurochem; 2017 Dec; 143(6):736-749. PubMed ID: 28881033
[TBL] [Abstract][Full Text] [Related]
6. Efficient clearance of Aβ protofibrils in AβPP-transgenic mice treated with a brain-penetrating bifunctional antibody.
Syvänen S; Hultqvist G; Gustavsson T; Gumucio A; Laudon H; Söderberg L; Ingelsson M; Lannfelt L; Sehlin D
Alzheimers Res Ther; 2018 May; 10(1):49. PubMed ID: 29793530
[TBL] [Abstract][Full Text] [Related]
7. Large aggregates are the major soluble Aβ species in AD brain fractionated with density gradient ultracentrifugation.
Sehlin D; Englund H; Simu B; Karlsson M; Ingelsson M; Nikolajeff F; Lannfelt L; Pettersson FE
PLoS One; 2012; 7(2):e32014. PubMed ID: 22355408
[TBL] [Abstract][Full Text] [Related]
8. A new class of monoclonal Aβ antibodies selectively targets and triggers deposition of Aβ protofibrils.
Grover S; Pham T; Jones A; Sinobas-Pereira C; Villoch Diaz Maurino M; Garrad EC; Makoni NJ; Parks A; Domalewski RJ; Riggio G; An H; Chen K; Nichols MR
J Neurochem; 2023 Jun; 165(6):860-873. PubMed ID: 37002186
[TBL] [Abstract][Full Text] [Related]
9. An amyloid-beta protofibril-selective antibody prevents amyloid formation in a mouse model of Alzheimer's disease.
Lord A; Gumucio A; Englund H; Sehlin D; Sundquist VS; Söderberg L; Möller C; Gellerfors P; Lannfelt L; Pettersson FE; Nilsson LN
Neurobiol Dis; 2009 Dec; 36(3):425-34. PubMed ID: 19703562
[TBL] [Abstract][Full Text] [Related]
10. Amyloid-beta protofibrils differ from amyloid-beta aggregates induced in dilute hexafluoroisopropanol in stability and morphology.
Nichols MR; Moss MA; Reed DK; Cratic-McDaniel S; Hoh JH; Rosenberry TL
J Biol Chem; 2005 Jan; 280(4):2471-80. PubMed ID: 15528204
[TBL] [Abstract][Full Text] [Related]
11. Amyloid-β42 protofibrils are internalized by microglia more extensively than monomers.
Gouwens LK; Makoni NJ; Rogers VA; Nichols MR
Brain Res; 2016 Oct; 1648(Pt A):485-495. PubMed ID: 27531183
[TBL] [Abstract][Full Text] [Related]
12. Dispersible amyloid β-protein oligomers, protofibrils, and fibrils represent diffusible but not soluble aggregates: their role in neurodegeneration in amyloid precursor protein (APP) transgenic mice.
Rijal Upadhaya A; Capetillo-Zarate E; Kosterin I; Abramowski D; Kumar S; Yamaguchi H; Walter J; Fändrich M; Staufenbiel M; Thal DR
Neurobiol Aging; 2012 Nov; 33(11):2641-60. PubMed ID: 22305478
[TBL] [Abstract][Full Text] [Related]
13. Separation and characterization of aggregated species of amyloid-beta peptides.
Wiberg H; Ek P; Pettersson FE; Lannfelt L; Emmer A; Roeraade J
Anal Bioanal Chem; 2010 Jul; 397(6):2357-66. PubMed ID: 20502882
[TBL] [Abstract][Full Text] [Related]
14. Amyloid-β(1-42) protofibrils formed in modified artificial cerebrospinal fluid bind and activate microglia.
Paranjape GS; Terrill SE; Gouwens LK; Ruck BM; Nichols MR
J Neuroimmune Pharmacol; 2013 Mar; 8(1):312-22. PubMed ID: 23242692
[TBL] [Abstract][Full Text] [Related]
15. Dihydrochalcone molecules destabilize Alzheimer's amyloid-β protofibrils through binding to the protofibril cavity.
Jin Y; Sun Y; Lei J; Wei G
Phys Chem Chem Phys; 2018 Jun; 20(25):17208-17217. PubMed ID: 29900443
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy to improve cognition and reduce pathological species in an Alzheimer's disease mouse model.
Herline K; Prelli F; Mehta P; MacMurray C; Goñi F; Wisniewski T
Alzheimers Res Ther; 2018 Jun; 10(1):54. PubMed ID: 29914551
[TBL] [Abstract][Full Text] [Related]
17. Disease modifying effects of the amyloid-beta protofibril-selective antibody mAb158 in aged Tg2576 transgenic mice.
Rizoska B; Zachrisson O; Appelkvist P; Boström E; Björklund M; Rachalski A; Gkanatsiou E; Kylefjord H; Söderberg L; Nygren P; Eriksson F; Ishikawa Y; Fukushima T; Koyama A; Osswald G; Lannfelt L; Möller C
Mol Cell Neurosci; 2024 Jun; 130():103950. PubMed ID: 38901655
[TBL] [Abstract][Full Text] [Related]
18. Amyloid-beta protofibril levels correlate with spatial learning in Arctic Alzheimer's disease transgenic mice.
Lord A; Englund H; Söderberg L; Tucker S; Clausen F; Hillered L; Gordon M; Morgan D; Lannfelt L; Pettersson FE; Nilsson LN
FEBS J; 2009 Feb; 276(4):995-1006. PubMed ID: 19215301
[TBL] [Abstract][Full Text] [Related]
19. A bispecific Tribody PET radioligand for visualization of amyloid-beta protofibrils - a new concept for neuroimaging.
Syvänen S; Fang XT; Hultqvist G; Meier SR; Lannfelt L; Sehlin D
Neuroimage; 2017 Mar; 148():55-63. PubMed ID: 28069541
[TBL] [Abstract][Full Text] [Related]
20. A Brain-Targeting Bispecific-Multivalent Antibody Clears Soluble Amyloid-Beta Aggregates in Alzheimer's Disease Mice.
Rofo F; Meier SR; Metzendorf NG; Morrison JI; Petrovic A; Syvänen S; Sehlin D; Hultqvist G
Neurotherapeutics; 2022 Sep; 19(5):1588-1602. PubMed ID: 35939261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
